Back
Protagenic Therapeutics 10K Form
Sell
9
PTIX
Protagenic Therapeutics
Last Price:
$3.53
Seasonality Move:
1.79%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PTIX News And Ratings
See the #1 stock for the next 7 days that we like better than PTIX
PTIX Financial Statistics
Sales & Book Value
| Annual Sales: | $85K |
|---|---|
| Cash Flow: | $-1.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.16 |
| Price / Book: | 1.61 |
Profitability
| EPS (TTM): | -13.10890 |
|---|---|
| Net Income (TTM): | $-5.2M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Protagenic Therapeutics Earnings Forecast
Key Protagenic Therapeutics Financial Ratios
-
The Selling, General & Administrative Expenses for PTIX have been equal to 891.76% of Gross Profit Margin.
-
Per Share Earnings over the last 25 years have been positive in 12 years.
Protagenic Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PTIX |
| Website: | protagenic.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PTIX Technical Analysis vs Fundamental Analysis
Sell
9
Protagenic Therapeutics (PTIX)
is a Sell
Is Protagenic Therapeutics a Buy or a Sell?
-
Protagenic Therapeutics stock is rated a SellThe current Protagenic Therapeutics [PTIX] share price is $3.45. The Score for PTIX is 9, which is 82% below its historic median score of 50, and infers higher risk than normal.